Major Findings: Developed LY3437943 (retatrutide), a novel triple agonist targeting the GLP-1, GIP, and glucagon receptors
Hamed K, Alosaimi MN, Ali BA, Alghamdi A, Alkhashi T, Alkhaldi SS et al (2024) Glucagon-like peptide-1 (GLP-1) receptor agonists: exploring their impact on diabetes, obesity, and cardiovascular health through a comprehensive literature review
Table of Contents: How do GLP-1 injections help with weight loss
Therefore, we believe that the discovery of low-cost oral GLP-1RA analogues or synergists and the continuous elucidation of the possible mechanism of action of GLP-1 are of great significance for the expansion of the field of disease treatment
As evidence mounts and patient interest grows, integrating these therapies into everyday practice becomes not just beneficial, but essential
Call iPharma Pharmacy at 1-844-779-0366 or email [email protected]